Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

The cannabis withdrawal syndrome: current insights.

Bonnet U, Preuss UW.

Subst Abuse Rehabil. 2017 Apr 27;8:9-37. doi: 10.2147/SAR.S109576. eCollection 2017. Review.

2.

Can tobacco dependence provide insights into other drug addictions?

DiFranza JR.

BMC Psychiatry. 2016 Oct 27;16(1):365. Review.

3.

Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction.

Kutlu MG, Gould TJ.

Learn Mem. 2016 Sep 15;23(10):515-33. doi: 10.1101/lm.042192.116. Print 2016 Oct.

PMID:
27634143
4.

Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.

Boileau I, Mansouri E, Williams B, Le Foll B, Rusjan P, Mizrahi R, Tyndale RF, Huestis MA, Payer DE, Wilson AA, Houle S, Kish SJ, Tong J.

Biol Psychiatry. 2016 Nov 1;80(9):691-701. doi: 10.1016/j.biopsych.2016.04.012. Epub 2016 Apr 25.

PMID:
27345297
5.

Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series.

Trigo JM, Soliman A, Staios G, Quilty L, Fischer B, George TP, Rehm J, Selby P, Barnes AJ, Huestis MA, Le Foll B.

J Addict Med. 2016 Jul-Aug;10(4):274-9. doi: 10.1097/ADM.0000000000000229.

6.

The Neurobiology of Cannabis Use Disorders: A Call for Evidence.

Lorenzetti V, Cousijn J, Solowij N, Garavan H, Suo C, Yücel M, Verdejo-García A.

Front Behav Neurosci. 2016 May 10;10:86. doi: 10.3389/fnbeh.2016.00086. eCollection 2016. No abstract available.

7.

fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users.

Filbey FM, Dunlop J, Ketcherside A, Baine J, Rhinehardt T, Kuhn B, DeWitt S, Alvi T.

Hum Brain Mapp. 2016 Oct;37(10):3431-43. doi: 10.1002/hbm.23250. Epub 2016 May 11.

8.

Psychosocial interventions for cannabis use disorder.

Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L.

Cochrane Database Syst Rev. 2016 May 5;(5):CD005336. doi: 10.1002/14651858.CD005336.pub4. Review.

9.

Screening Medications for the Treatment of Cannabis Use Disorder.

Panlilio LV, Justinova Z, Trigo JM, Le Foll B.

Int Rev Neurobiol. 2016;126:87-120. doi: 10.1016/bs.irn.2016.02.005. Epub 2016 Mar 10. Review.

10.

Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.

Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B.

Drug Alcohol Depend. 2016 Apr 1;161:298-306. doi: 10.1016/j.drugalcdep.2016.02.020. Epub 2016 Feb 23.

11.
12.

Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.

Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, Nunes EV, Bisaga A, Dakwar E, Carpenter KM, Sullivan MA, Choi JC.

Drug Alcohol Depend. 2016 Feb 1;159:53-60. doi: 10.1016/j.drugalcdep.2015.11.025. Epub 2015 Nov 27.

13.

Altered subjective reward valuation among drug-deprived heavy marijuana users: Aversion to uncertainty.

Hefner KR, Starr MJ, Curtin JJ.

J Abnorm Psychol. 2016 Jan;125(1):138-50. doi: 10.1037/abn0000106. Epub 2015 Nov 23.

14.

Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users.

Herrmann ES, Weerts EM, Vandrey R.

Exp Clin Psychopharmacol. 2015 Dec;23(6):415-21. doi: 10.1037/pha0000053. Epub 2015 Oct 12.

15.

Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.

McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J.

Drug Alcohol Depend. 2015 Nov 1;156:29-37. doi: 10.1016/j.drugalcdep.2015.08.013. Epub 2015 Aug 25.

16.

Marijuana's acute effects on cognitive bias for affective and marijuana cues.

Metrik J, Aston ER, Kahler CW, Rohsenow DJ, McGeary JE, Knopik VS.

Exp Clin Psychopharmacol. 2015 Oct;23(5):339-50. doi: 10.1037/pha0000030. Epub 2015 Jul 13.

17.

Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.

Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU.

Psychopharmacology (Berl). 2015 Aug;232(15):2751-61. doi: 10.1007/s00213-015-3907-0. Epub 2015 Mar 15.

18.

Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race.

Soenksen S, Stein LA, Brown JD, Stengel JR, Rossi JS, Lebeau R.

J Child Adolesc Subst Abuse. 2015 Apr 1;24(2):119-124.

19.

Craving is associated with amygdala volumes in adolescent marijuana users during abstinence.

Padula CB, McQueeny T, Lisdahl KM, Price JS, Tapert SF.

Am J Drug Alcohol Abuse. 2015 Mar;41(2):127-32. doi: 10.3109/00952990.2014.966198. Epub 2015 Feb 10.

20.

Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.

Lam PW, Frost DW.

BMJ Case Rep. 2014 Sep 22;2014. pii: bcr2014205287. doi: 10.1136/bcr-2014-205287.

Supplemental Content

Support Center